Objective Antipsychotic effects of immunomodulating drugs have been suggested; however,
a thorough, comprehensive meta-analysis on the effect and safety of anti-inflammatory add …

Question This umbrella review and guidelines aimed to provide evidence to support the
rational choice of selected adjunctive therapies for schizophrenia. Study selection and …

Background and hypothesis Several studies suggest that raloxifene, a selective estrogen
receptor modulator, improves symptoms and cognition in post-menopausal women with …

Women show a heightened risk for psychosis in midlife that is not observed in men. The
menopausal transition (ie perimenopause) and accompanying changes in ovarian …

Abstract Purpose of Review Despite clear evidence that sex differences largely impact the
efficacy and tolerability of antipsychotic medication, current treatment guidelines for …

Objectives We conducted a comprehensive meta‐analysis of all available trials to evaluate
the efficacy and safety of estrogen and selective estrogen receptor modulators as adjunctive …

The link between sex hormones and schizophrenia has been suspected for over a century;
however, scientific evidence supporting the pharmacotherapeutic effects of exogenous …

Background: It has been hypothesized that, whenever estrogen levels decline, psychosis
symptoms in women increase. At menopause, this can happen in two main ways:(a) the loss …

In both animals and human beings, males and females differ in their genetic background
and hormonally driven behaviour and show sex-related differences in brain activity and …

Schizophrenia is characterized by symptoms of psychosis and sociocognitive deficits.
Considering oxytocin's antipsychotic and prosocial properties, numerous clinical, and …